ADAPTIMMUNE THERAPEUTICS PLC Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $8.49 million as of 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Additional Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-03-24
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $8.49M.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.70M.
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.90M.
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $18.89M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2024-12-31 | $8.49M 10-K · filed 2025-03-24 |
| 2023-12-31 | $9.70M 10-K · filed 2024-03-06 |
| 2022-12-31 | $14.90M 10-K · filed 2023-03-06 |
| 2021-12-31 | $18.89M 10-K · filed 2022-03-14 |
| 2020-12-31 | $11.88M 10-K · filed 2021-02-25 |
| 2019-12-31 | $10.03M 10-K · filed 2020-02-27 |
| 2018-12-31 | $13.69M 10-K · filed 2019-02-27 |
| 2017-12-31 | $10.09M 10-K · filed 2018-03-15 |
| 2016-12-31 | $7.92M 10-K · filed 2017-03-13 |
| 2015-12-31 | $7.67M 8-K · filed 2016-07-08 |